AcquisitionOther
Turning Point Therapeutics, Inc. acquired Bristol-Myers Squibb Company
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Turning Point Therapeutics, Inc. -> Bristol-Myers Squibb Company · $0.0001
Each of the Company’s stock options (the “ Options ”) that is outstanding as of immediately prior to the Effective Time will accelerate and become fully vested and exercisable effective immediately prior to, and contingent upon the occurrence of, the Effective
Open source record (SEC) ↗